These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Biochemical substrates of mental disturbances in Parkinson's disease. Agid Y; Ruberg M; Dubois B; Javoy-Agid F Adv Neurol; 1984; 40():211-8. PubMed ID: 6695597 [No Abstract] [Full Text] [Related]
5. Drug-induced changes in brain dopamine and their relation to parkinsonism. Vogt M Sci Basis Med Annu Rev; 1970; ():276-91. PubMed ID: 4319923 [No Abstract] [Full Text] [Related]
7. [Influencing of Parkinson's syndrome via intervention in the dopamine metabolism]. Korten JJ; van Rossum JM Ned Tijdschr Geneeskd; 1973 Feb; 117(8):296-305. PubMed ID: 4350090 [No Abstract] [Full Text] [Related]
12. [The role of brain dopamine]. Rybakowski J Psychiatr Pol; 1972; 6(3):341-4. PubMed ID: 4560234 [No Abstract] [Full Text] [Related]
13. [L-threo-DOPS therapy and parkinsonism]. Narabayashi H No To Shinkei; 1986 Jan; 38(1):60-2. PubMed ID: 3083844 [No Abstract] [Full Text] [Related]
14. Dopaminergic mechanisms in patients with extrapyramidal disease. Chase TN; Shoulson I Adv Neurol; 1975; 9():359-66. PubMed ID: 1146660 [No Abstract] [Full Text] [Related]
15. [Thoughts on the neurobiological aspects of Parkinson syndrome]. Sommer H Psychiatr Neurol Med Psychol (Leipz); 1986 Feb; 38(2):86-90. PubMed ID: 3010357 [TBL] [Abstract][Full Text] [Related]